GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
246 hedge funds and large institutions have $4.73B invested in Global Blood Therapeutics, Inc. in 2022 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 54 increasing their positions, 58 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
27% more funds holding
Funds holding: 194 → 246 (+52)
7% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 58
Holders
246
Holding in Top 10
21
Calls
$145M
Puts
$86.1M
Top Buyers
| 1 | +$218M | |
| 2 | +$154M | |
| 3 | +$152M | |
| 4 |
JP Morgan Chase
New York
|
+$129M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$96.2M |
Top Sellers
| 1 | -$226M | |
| 2 | -$178M | |
| 3 | -$173M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$156M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$141M |